BenchmarkIn progress
Uncertainty-aware multi-model prioritisation of NDM-1 inhibitors
Known-active/known-negative benchmark design and prospective validation framework.
Bayes Pharma Scientific Library
The evidence context stays attached.
Search research materials by title, programme, format and evidence level. Planned or in-progress work is labelled explicitly and is never presented as peer-reviewed publication.
Evidence mapIn progress
Small-molecule adjuncts for snakebite envenoming in India
Target, inhibitor and translational-gap map for venom enzyme inhibition.
ProtocolPlanned
Cross-serotype NS5 structural robustness benchmark
Planned benchmark specification for serotype-aware NS5 inhibitor prioritisation.